These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 3668252)

  • 1. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
    Rotrosen D; Malech HL; Gallin JI
    J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.
    Marasco WA; Feltner DE; Ward PA
    J Cell Biochem; 1985; 27(4):359-75. PubMed ID: 2987275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM; Huang CK; Becker EL
    J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
    Borish L; O'Reilly D; Klempner MS; Rocklin RE
    J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L; Aksamit RR
    J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.
    Charest-Morin X; Roy C; Fernandes MJ; Marceau F
    Int Immunopharmacol; 2015 Mar; 25(1):229-34. PubMed ID: 25681283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils.
    Atkinson YH; Lopez AF; Marasco WA; Lucas CM; Wong GG; Burns GF; Vadas MA
    Immunology; 1988 Jul; 64(3):519-25. PubMed ID: 2842255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
    Fletcher MP; Seligmann BE; Gallin JI
    J Immunol; 1982 Feb; 128(2):941-8. PubMed ID: 6274963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors.
    Weisbart RH; Golde DW; Gasson JC
    J Immunol; 1986 Dec; 137(11):3584-7. PubMed ID: 3491142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor.
    Honda S; Campbell JJ; Andrew DP; Engelhardt B; Butcher BA; Warnock RA; Ye RD; Butcher EC
    J Immunol; 1994 Apr; 152(8):4026-35. PubMed ID: 7511663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Becker EL
    J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tunicamycin on the expression and function of formyl peptide chemotactic receptors of differentiated HL-60 cells.
    Heiman DF; Gardner JP; Apfeldorf WJ; Malech HL
    J Immunol; 1986 Jun; 136(12):4623-30. PubMed ID: 3011898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
    Dentino AR; Raj PA; De Nardin E
    Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
    Andersson T; Dahlgren C; Pozzan T; Stendahl O; Lew PD
    Mol Pharmacol; 1986 Nov; 30(5):437-43. PubMed ID: 2430168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
    Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
    J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
    Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.